Study of taking blood thinners and quality of life in cancer clots
Part of Blood & lymphatic, Cancer clinical trials.
This study looks at how people with cancer-related blood clots in the leg or lungs do with anticoagulant (blood thinner) treatment over at least 3 months. It also tracks quality of life and healthcare use, which may help improve supportive care for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 or older, and you can speak/read English.
- You recently had a confirmed symptomatic blood clot in the leg (deep vein thrombosis) and/or a pulmonary embolism (lung clot).
- Your blood clot is related to cancer (not just a skin cancer like basal or squamous), either currently active or diagnosed within the past 2 years.
- Your doctor plans for you to take blood thinners for at least 3 months.
- You can join within the first 5 days after starting anticoagulation and complete surveys.
- You’re not expected to die within 3 months and your mobility/health is not extremely poor (ECOG not 4).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who have both cancer and a blood clot. It aims to learn more about how these clots happen and how they are treated in cancer patients, so doctors can improve care.
This study looks at how well blood thinners (anticoagulants) work in people with cancer who have had a blood clot. It aims to compare the benefits and risks of different anticoagulant medicines.
This study looks at how to best treat blood clots in veins near the skin in people who also have active cancer. It will compare different treatment options to find what works best and is safest for you.
This trial tests a new anticoagulant medication to treat and prevent blood clots in patients with active cancer. You may qualify if you have a recent clot in your leg or lungs and are already taking a blood thinner.
This study follows patients who have had a blood clot in their leg or lung to learn more about their health over time. It helps doctors understand how to better care for people with blood clots.
This study is for people with cancer who have had a serious blood clot. Researchers want to create a risk score that predicts who might have another clot or a bleeding problem from treatment, so they can better tailor care.
Hear when a new Cancer-related Venous Thromboembolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.